Frölich L. EU - Europäische Union : Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer's Disease. 10/2023-09/2027.
Hausner L. Roche Pharma AG : A Phase II, randomized, double-blind, placebo-controlled, multiple dose, parallel-group study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7269162 following oral administration in participants at risk for or at the .
Hausner L. : A Phase 2/3 Double-Blind, Randomized, Placebo-Controlled Adaptive Design Trial to Evaluate the Efficacy and Safety of Intravenous ACU193 in Early Alzheimer’s Disease.
